NASDAQ:MCRB | Cash Flow Statement | Seres Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$4.58M$670,000.00
2026-03-31-$19.91M$781,000.00-$16.36M$0.00$0.00$428,000.00
2025-12-31-$15.34M$954,000.00-$14.71M$29,000.00$181,000.00$12.66M
2025-09-30$8.2M$1.04M
2025-06-30-$19.86M$1.06M
2025-03-31$32.68M$1.08M$26.91M$34,000.00-$34,000.00$1.18M
2024-12-31-$15.64M$1.09M-$38.88M$90,000.00-$90,000.00$1.74M
2024-09-30$88.78M$1.4M
2024-06-30-$32.87M$1.42M
2024-03-31-$40.13M$1.56M-$35.24M$62,000.00-$62,000.00$18.76M
2023-12-31-$41.25M$1.63M-$47.5M$877,000.00-$877,000.00$6.43M
2023-09-30-$47.85M$1.68M
2023-06-30$46.55M$1.53M
2023-03-31-$71.17M$1.4M-$76.58M$4.07M$2.74M$5.66M
2022-12-31-$68.8M$1.63M-$52.89M$3.46M$5.93M$4.6M
2022-09-30-$60M$1.75M
2022-06-30-$64.74M$1.69M
2022-03-31-$56.62M$1.57M-$66.45M$2.95M$12.97M$26.85M
2021-12-31-$50M$1.55M-$51.86M$1.58M$13.19M-$780,000.00
2021-09-30$68.22M$1.49M
2021-06-30-$48.33M$1.43M
2021-03-31-$35.47M$1.48M-$29.5M$1.34M-$20.74M$764,000.00
2020-12-31-$18.25M$1.51M-$17.93M$226,000.00-$75.34M$1.99M
2020-09-30-$30.28M$1.58M
2020-06-30-$20.71M$1.69M
2020-03-31-$19.88M$1.8M-$24.25M$71,000.00$9.44M$4.55M
2019-12-31-$18.78M$1.8M-$14.05M$230,000.00$4.65M$25.11M
2019-09-30-$16.41M$1.88M
2019-06-30-$10.76M$1.92M
2019-03-31-$24.33M$2.01M-$32.39M$306,000.00-$306,000.00$480,000.00
2018-12-31-$21.29M$1.99M$12.67M-$196,000.00$17.4M$45,000.00
2018-09-30-$21.95M$1.97M
2018-06-30-$27.79M$1.95M
2018-03-31-$27.92M$1.94M-$26.76M$953,000.00$38.03M-$165,000.00
2017-12-31-$28.95M$1.9M-$20.61M$685,000.00$9.3M-$25,000.00
2017-09-30-$6.94M$1.87M
2017-06-30-$28.02M$1.76M
2017-03-31-$25.47M$1.73M-$25.65M$2.25M
2016-12-31-$25.28M$1.69M-$20.81M$5.69M
2016-09-30-$18.69M$1.25M
2016-06-30-$27.91M$874,000.00
2016-03-31-$19.7M$386,000.00$101.42M$3.4M
2015-12-31-$19.63M$334,000.00-$11.57M$1.24M
2015-09-30-$14.62M$182,000.00
2015-06-30-$12.56M$119,000.00
2015-03-31-$12.56M$92,000.00-$8.34M$214,000.00
2014-12-31-$8.18M$77,000.00-$4.12M$374,000.00
2014-09-30-$4.16M$47,000.00
2014-06-30-$2.68M$36,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$5.7M$4.13M$1.12M$252,000.00-$42,000.00$13.9M
2024-12-31$136,000.00$5.47M-$148.61M$380,000.00$142.29M-$90.37M
2023-12-31-$113.72M$6.24M-$117.35M$7.98M$10.58M$71.71M
2022-12-31-$250.16M$6.63M-$228.82M$9.82M$82.43M$129.6M
2021-12-31-$65.58M$5.95M$6.69M$9.57M$64.09M$1.18M
2020-12-31-$89.13M$6.58M-$93.61M$591,000.00-$158.89M$303.42M
2019-12-31-$70.28M$7.6M-$76.52M$1M-$30.52M$86.23M
2018-12-31-$98.94M$7.86M-$62.85M$1.94M$112.32M$268,000.00
2017-12-31-$89.38M$7.26M-$75.52M$4.68M$55.7M$33,000.00$83,000.00
2016-12-31-$91.58M$4.21M$43.92M$21.49M-$65.59M$2.14M
2015-12-31-$54.78M$728,000.00-$40.84M$4.36M
2014-12-31-$16.71M$190,000.00-$10.36M$1M
2013-12-31-$6.1M$88,000.00-$5.32M$174,000.00